Lung Diseases, Interstitial
85
14
19
42
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
18 trials with published results (21%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
8.2%
7 terminated out of 85 trials
85.7%
-0.8% vs benchmark
14%
12 trials in Phase 3/4
43%
18 of 42 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 42 completed trials
Clinical Trials (85)
Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients
Lung Cancer Screening CT for Firefighters
NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases
Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan
Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
Database for Interstitial Lung Disease
Cough Capture as a Portal Into the Lung
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung Diseases
Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors
Dorothy P. and Richard P. Simmons Center for ILD Research Registry
INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation
A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease
Identification of Novel Markers of Human Lung Disease
Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)